Optimal medical therapy (OMT) is underutilized in patients with complex coronary disease who undergo revascularization with PCI but especially so for those treated with CABG, according to data from ...
SAN FRANCISCO, CALIF.—Four-year results from the SYNTAX trial show that most patients with three-vessel disease continue to derive more benefit from CABG than from PCI. But in patients with left main ...
The 3-year results of the SYNTAX trial, according to data presented by Patrick W. Serruys, MD, PhD, suggested that percutaneous coronary intervention is a reasonable alternative to CABG for patients ...
BARCELONA — Final, five-year results from the SYNTAX trial comparing CABG surgery and PCI with a drug-eluting stent (DES) in patients with complex coronary disease confirm the message that started to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback